83. Dokl Biochem Biophys. 2018 Jan;478(1):37-40. doi: 10.1134/S1607672918010106. Epub2018 Mar 14.Messenger RNA of the Histidine-Rich Glycoprotein in Breast Tumors.Autenshlyus AI(1)(2), Brusentsov II(3)(4), Marinkin IO(3), Smirnova SA(5),Rukavishnikov MY(5), Lyakhovich VV(6).Author information: (1)Ministry of Healthcare of the Russian Federation, Novosibirsk State MedicalUniversity, Novosibirsk, 630091, Russia. lpciip@211.ru.(2)Research Institute of Molecular Biology and Biophysics, Novosibirsk, 630117,Russia. lpciip@211.ru.(3)Ministry of Healthcare of the Russian Federation, Novosibirsk State MedicalUniversity, Novosibirsk, 630091, Russia.(4)Federal Research Center Institute of Cytology and Genetics, Siberian Branch,Russian Academy of Sciences, Novosibirsk, 630090, Russia.(5)JSC Vector-Best, Kol'tsovo, Novosibirsk oblast, 633159, Russia.(6)Research Institute of Molecular Biology and Biophysics, Novosibirsk, 630117,Russia.The content of mRNA of the histidine-rich glycoprotein (HRG), a potential marker of malignant neoplasia, which can be used in differential diagnosis of breasttumors, was determined in 110 breast tumor biopsy samples. The presence of HRGmRNA did not depend on the cancer type, on the preoperative treatment or itsabsence, as well as on the tumor progression stage and the presence ofmetastases.DOI: 10.1134/S1607672918010106 PMID: 29536307  [Indexed for MEDLINE]